Eczema in Adults: A London Dermatologist’s Guide to Long-Term Control

Adult eczema treatment London

---

By Dr Hiba Injibar | Consultant Dermatologist, Dermasurge Harley Street

Adult eczema is rarely the same condition you remember from childhood. The itch is older, the triggers are more layered, and the skin barrier has had decades of weather, stress, soap, and steroid cycles to contend with. Many patients arrive at Dermasurge Clinic after years of patching the problem: a tube of hydrocortisone from the pharmacy, an emollient that helps for a week, a flare that always returns. The frustrating reality is that atopic dermatitis in adults is a chronic inflammatory condition that needs a properly structured long-term plan, not a holding pattern.

This guide explains how a consultant dermatologist approaches adult eczema treatment in London, what realistic control looks like, and when escalation to systemic therapy is appropriate.

What is atopic eczema in adults?

Atopic dermatitis is a chronic, relapsing inflammatory skin condition driven by a combination of skin barrier dysfunction, immune dysregulation, and environmental triggers. In adults, it can present in three broad patterns: continuation from childhood, recurrence after a long quiet period, or genuine adult-onset disease appearing for the first time in someone’s twenties, thirties, or beyond.

Clinically, adult eczema often looks different from the textbook flexural pattern seen in children. Common adult presentations include:

• Hand eczema, particularly in patients with occupational wet-work exposure
• Eyelid and periocular eczema, often confused with allergic contact dermatitis
• Head-and-neck eczema, sometimes linked to Malassezia yeast sensitivity
• Nummular (discoid) patches on the limbs
• Generalised, poorly demarcated dryness with lichenification on areas that have been rubbed or scratched chronically

Because the presentation is variable, accurate diagnosis matters. Several other conditions mimic eczema, including allergic contact dermatitis, psoriasis, cutaneous T-cell lymphoma in its early stages, and seborrhoeic dermatitis. A proper consultation rules these in or out before treatment is escalated.

---

Why eczema becomes chronic in adults

The drivers of persistent atopic dermatitis in adults are usually multifactorial. Genetics contribute through filaggrin mutations and other barrier-protein variants, but lifestyle and environment carry significant weight in adulthood.

Skin barrier dysfunction

A compromised stratum corneum loses water rapidly and allows irritants and allergens to penetrate more easily. This sets up a cycle: dryness, inflammation, scratching, further barrier disruption. Most adult patients underestimate how much emollient their skin actually needs, and how often.

Trigger accumulation

Adults rarely react to a single trigger. The picture is usually cumulative: hard London tap water, fragranced detergents, central heating, alcohol-based hand sanitisers, stress, poor sleep, hormonal shifts, and occasional food or aeroallergen contributions. Identifying the top three to five contributors is more useful than chasing a single culprit.

Microbial drivers

Staphylococcus aureus colonisation is common in eczematous skin and can drive flares through superantigen activity. Recognising infected or colonised eczema (weeping, crusting, sudden worsening) is part of the assessment, because untreated infection blocks any topical regimen from working.

---

The consultant dermatology approach to long-term control

Sustainable control depends on five pillars, applied in the right order and to the right intensity for the individual patient.

1. Accurate diagnosis and trigger mapping

The first consultation focuses on confirming atopic eczema, distinguishing it from look-alikes, and mapping likely triggers. Patch testing is often appropriate where contact allergy is suspected, particularly in hand and eyelid eczema. Bloodwork may be requested where systemic therapy is being considered.

2. Structured barrier repair

Emollient therapy is the foundation of every plan, but it has to be done properly. That means choosing a vehicle the patient will actually use (cream, ointment, or lotion based on skin type and lifestyle), applying it generously (typically 250-500g per week for a moderately affected adult), and timing application to follow bathing while skin is still damp. Soap substitutes replace foaming washes. Showers are kept short and lukewarm.

3. Topical anti-inflammatory therapy

Topical corticosteroids remain first-line for active inflammation, and their reputation for “thinning the skin” is largely the result of misuse rather than appropriate prescription. A consultant dermatologist will match steroid potency to body site and severity, set a clear treatment duration, and step down through a maintenance phase. Topical calcineurin inhibitors are used for facial, eyelid, and flexural sites where long-term steroid use is undesirable. Newer non-steroidal options, including topical PDE4 inhibitors and topical JAK inhibitors, are now part of the dermatologist’s armamentarium for selected patients.

4. Proactive maintenance

Reactive treatment alone (only treating visible flares) tends to produce a sawtooth pattern of partial control followed by relapse. Proactive maintenance, where a low-potency topical anti-inflammatory is applied twice weekly to historical hotspots even when the skin looks clear, significantly reduces flare frequency for most patients. This is one of the most under-used strategies in primary care eczema management.

5. Escalation when needed

If well-applied topical therapy fails to control disease, or if the burden of disease is significant (sleep disruption, occupational impact, mental health impact), systemic options are considered. These are discussed in detail below.

---

Systemic options for chronic eczema

For moderate-to-severe chronic eczema treatment, several systemic pathways are available. Each has a specific patient profile, monitoring requirement, and expected timeline.

Phototherapy

Narrowband UVB is a well-established option for widespread eczema in patients who can attend a course of treatments, typically two to three times weekly over several weeks. It is steroid-sparing and suits patients who want to avoid oral immunosuppression.

Conventional immunosuppressants

Ciclosporin, methotrexate, azathioprine, and mycophenolate mofetil have all been used in adult eczema. They require baseline screening, regular blood monitoring, and a clear conversation about side-effect profile and pregnancy planning. They remain useful, particularly for short-term flare control with ciclosporin, but the landscape has shifted significantly with the arrival of targeted therapy.

Biologics and targeted small molecules

Biologic therapy targeting interleukin-4 and interleukin-13 signalling has transformed outcomes for moderate-to-severe atopic dermatitis. Oral JAK inhibitors offer another targeted route. These are prescribed by consultant dermatologists, with eligibility criteria based on disease severity and response to prior treatments. For the right patient, the impact on itch, sleep, and quality of life can be substantial. Results vary, and treatment is personalised.

---

Eczema flare management: what to do in the moment

Even with good long-term control, flares happen. Effective eczema flare management follows a planned sequence rather than panic prescribing.

• Recognise early. Increased itch, pinkness, and roughness precede visible inflammation by a day or two. Treating at this stage shortens the flare.
• Step up topical potency for a defined period. A short, intensive course of the appropriate steroid potency is usually more effective than prolonged use of an under-potent one.
• Check for infection. Weeping, yellow crust, or sudden worsening warrants assessment for bacterial or viral (eczema herpeticum) infection.
• Address the trigger. Recent travel, new detergent, illness, stress event, or seasonal shift. Identifying the precipitant reduces recurrence.
• Return to maintenance. Once the flare is controlled, step down through maintenance dosing rather than stopping abruptly.

---

Why choose Dermasurge Clinic for adult eczema

Dermasurge Clinic is a consultant-led dermatology practice in central London. Assessments are carried out by Dr Hiba Injibar, consultant dermatologist on the GMC specialist register, with extensive experience managing chronic inflammatory skin conditions in adults.

What distinguishes the pathway here:

• Consultant-led from the first appointment. No triage through non-specialist staff. The dermatologist sees you, examines the skin, and forms the plan.
• Medical and cosmetic dermatology under one roof. Patients with eczema often develop post-inflammatory pigmentation or textural change after years of flares. Having medical and cosmetic dermatology integrated means the residual effects can be addressed within the same clinical relationship.
• On-site M22, Q-switched, and IPL platforms. Useful where post-eczema pigmentation or persistent erythema needs targeted treatment once the underlying inflammation is controlled.
• Evidence-based, personalised treatment plans. Decisions are guided by the British Association of Dermatologists’ guidance, current clinical evidence, and the individual patient’s history, lifestyle, and goals.

For more information on our broader approach, see the Dermasurge Clinic homepage and our eczema condition page. Patients managing related concerns may also find our guide to rosacea management in London useful, as the principles of chronic inflammatory skin care overlap.

Assessment with a consultant dermatologist is required to determine the appropriate treatment for adult eczema.

---

What realistic long-term control looks like

Patients sometimes arrive expecting a cure. Honest framing helps: atopic eczema is a long-term condition, but for the majority of adults it can be brought to a state where flares are infrequent, mild, and quickly resolved. Most patients find that with a properly structured plan, day-to-day skin is comfortable, sleep is uninterrupted, and the cycle of crisis-treatment-relapse loosens. Sustained control typically requires sustained engagement: emollients continue, maintenance topicals continue, and review appointments check that the plan is still fit for purpose as life circumstances change.

---

Frequently asked questions

Can adult-onset eczema appear for the first time in your thirties or forties?

Yes. Genuine adult-onset atopic dermatitis is well recognised and can appear at any age. Hormonal shifts, occupational exposures, significant stress events, and changes in skincare habits can all contribute. A consultant dermatologist will confirm the diagnosis and exclude mimics such as allergic contact dermatitis or other inflammatory dermatoses before treatment is planned.

Are topical steroids safe to use long-term?

When prescribed and supervised appropriately, topical corticosteroids remain a safe and effective cornerstone of eczema treatment. The risks associated with long-term use are largely linked to using too potent a strength on delicate skin, using them indefinitely without review, or abrupt cessation after prolonged unsupervised use. A consultant-led plan matches potency to body site and includes a defined step-down and maintenance strategy.

When should I consider systemic treatment for eczema?

Systemic therapy is considered when well-applied topical treatment fails to control disease, when eczema is widespread, or when its impact on sleep, work, mental health, or quality of life is significant. Options range from phototherapy and conventional immunosuppressants to biologic therapy and oral JAK inhibitors. Eligibility, monitoring, and prescribing are managed by a consultant dermatologist.

Does diet cause adult eczema?

For most adults, food is not a primary driver of atopic eczema, although a small subset of patients identify specific food triggers. Restrictive diets are rarely helpful and can cause nutritional harm if pursued without guidance. Where food allergy is suspected, formal assessment is more useful than self-elimination.

How long does it take to see improvement with a dermatologist-led plan?

Most patients see meaningful improvement in active inflammation within two to four weeks of starting an appropriately structured topical regimen. Longer-term control, including reduced flare frequency, typically becomes apparent over three to six months as proactive maintenance and trigger management take effect. Timelines vary depending on disease severity and individual response.

---

Book a consultation

If adult eczema has been ongoing despite over-the-counter treatments and GP-led care, a consultant dermatology assessment will clarify the diagnosis and structure a plan for long-term control. Book a consultation at Dermasurge Clinic.

---